Sale!

Myeloproliferative Neoplasia MPN Panel BCR QLT JAK2 PANEL CALR MPL Test Cost

Original price was: 5,600 د.إ.Current price is: 4,200 د.إ.

-25%

The Myeloproliferative Neoplasia (MPN) Panel is a comprehensive diagnostic test designed to identify genetic mutations associated with myeloproliferative disorders, which are a group of diseases that cause blood cells to grow abnormally in the bone marrow. This panel specifically targets mutations in the BCR-ABL1, JAK2, CALR, and MPL genes, which are crucial for diagnosing and managing conditions such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

Performed at DNA Labs UAE, a leading facility in genetic testing, the MPN Panel leverages qualitative techniques (QLT) to accurately detect the presence of these mutations. The inclusion of the BCR-ABL1 gene in the panel is particularly important for distinguishing between chronic myeloid leukemia and other MPN disorders, as it is the hallmark mutation of chronic myeloid leukemia.

The cost of the MPN Panel at DNA Labs UAE is 4200 AED. This investment covers the comprehensive analysis required to identify the genetic underpinnings of myeloproliferative neoplasms, which is essential for guiding treatment decisions and predicting patient outcomes. Given the complexity and the detailed genetic insights provided by this panel, it represents a critical step towards personalized medicine in the management of myeloproliferative disorders.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Myeloproliferative Neoplasia MPN Panel BCR QLTJAK2 PANELCALR MPL Test Price 4200 AED

Test Name:

Myeloproliferative Neoplasia MPN Panel BCR QLTJAK2 PANELCALR MPL Test

Components:

EDTA Vacutainer (2ml)

Price:

4200.0 AED

Sample Condition:

Bone marrow / Peripheral blood (Transport immediately)

Report Delivery:

5-7 days

Method:

Real Time PCR + Sanger Sequencing

Test type:

Genetics

Doctor: Gynecologist

Test Department:

Pre Test Information

Myeloproliferative Neoplasia (MPN) Panel (BCR QLT,JAK2 PANEL,CALR, MPL) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Test Details:

The Myeloproliferative Neoplasia (MPN) Panel is a diagnostic test used to detect genetic mutations associated with myeloproliferative neoplasms, a group of blood disorders characterized by the overproduction of certain types of blood cells.

The panel includes the following genetic tests:

  1. BCR-ABL1 Quantitative PCR (BCR QLT): This test is used to detect the BCR-ABL1 fusion gene, which is a genetic abnormality commonly found in chronic myeloid leukemia (CML). The presence of this fusion gene helps in the diagnosis and monitoring of CML.
  2. JAK2 Panel: This panel includes tests for mutations in the JAK2 gene, specifically the V617F mutation. The JAK2 V617F mutation is found in a majority of patients with polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Detection of this mutation is essential for the diagnosis of these MPNs.
  3. CALR Mutation Analysis: This test is used to detect mutations in the CALR gene, which is also associated with MPNs, particularly essential thrombocythemia and primary myelofibrosis. CALR mutations are mutually exclusive with JAK2 and MPL mutations and are found in a significant proportion of patients with these MPNs.
  4. MPL Mutation Analysis: This test detects mutations in the MPL gene, which is another gene associated with MPNs, specifically essential thrombocythemia and primary myelofibrosis. MPL mutations are mutually exclusive with JAK2 and CALR mutations and are found in a small subset of patients with these MPNs.

By analyzing these genetic mutations, the MPN panel helps in the diagnosis, risk stratification, and monitoring of patients with myeloproliferative neoplasms.

Test NameMyeloproliferative Neoplasia MPN Panel BCR QLTJAK2 PANELCALR MPL Test
ComponentsEDTA Vacutainer (2ml)
Price 4200.0 AED
Sample ConditionBone marrow \/ Peripheral blood (Transport immediately)
Report Delivery5-7 days
MethodReal Time PCR + Sanger Sequencing
Test typeGenetics
DoctorGynecologist
Test Department:
Pre Test InformationMyeloproliferative Neoplasia (MPN) Panel (BCR QLT,JAK2 PANEL,CALR, MPL) can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test DetailsThe Myeloproliferative Neoplasia (MPN) Panel is a diagnostic test used to detect genetic mutations associated with myeloproliferative neoplasms, a group of blood disorders characterized by the overproduction of certain types of blood cells. The panel includes the following genetic tests:

1. BCR-ABL1 Quantitative PCR (BCR QLT): This test is used to detect the BCR-ABL1 fusion gene, which is a genetic abnormality commonly found in chronic myeloid leukemia (CML). The presence of this fusion gene helps in the diagnosis and monitoring of CML.

2. JAK2 Panel: This panel includes tests for mutations in the JAK2 gene, specifically the V617F mutation. The JAK2 V617F mutation is found in a majority of patients with polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). Detection of this mutation is essential for the diagnosis of these MPNs.

3. CALR Mutation Analysis: This test is used to detect mutations in the CALR gene, which is also associated with MPNs, particularly essential thrombocythemia and primary myelofibrosis. CALR mutations are mutually exclusive with JAK2 and MPL mutations and are found in a significant proportion of patients with these MPNs.

4. MPL Mutation Analysis: This test detects mutations in the MPL gene, which is another gene associated with MPNs, specifically essential thrombocythemia and primary myelofibrosis. MPL mutations are mutually exclusive with JAK2 and CALR mutations and are found in a small subset of patients with these MPNs.

By analyzing these genetic mutations, the MPN panel helps in the diagnosis, risk stratification, and monitoring of patients with myeloproliferative neoplasms.